Adverse Effects

Citations 251-260 of 590 total displayed.

Past content (since Mar 1998):

Editorials
Cardiovascular Risk and the Thiazolidinediones: Déjà Vu All Over Again?

Daniel H. Solomon; Wolfgang C. Winkelmayer
JAMA 2007; 298: 1216-1218. [Extract] [Full text] [PDF]  

Medical News & Perspectives
Postmarket "Pharmacovigilance" Program on Alert for Adverse Events From Drugs

Tracy Hampton
JAMA 2007; 298: 851-852. [Extract] [Full text] [PDF]  

Letters
Benefits and Harms of Pediatric Antidepressant Medications

Jonathan L. Edwards; Karen K. Kirk; Chand K. Midha
JAMA 2007; 298: 626-a-627-a. [Extract] [Full text] [PDF]  

Letters
Benefits and Harms of Pediatric Antidepressant Medications

Bruce Waslick
JAMA 2007; 298: 626. [Extract] [Full text] [PDF]  

Letters
Benefits and Harms of Pediatric Antidepressant Medications—Reply

Jeffrey A. Bridge; Boris Birmaher; David A. Brent
JAMA 2007; 298: 627-b. [Extract] [Full text] [PDF]  

Medical News & Perspectives
Research Findings Point to Advances in Breast Cancer Screening and Treatment

Tracy Hampton
JAMA 2007; 298: 389-390. [Extract] [Full text] [PDF]  

Commentaries
Improving Detection of Adverse Effects of Marketed Drugs

Donald F. Klein; Charles P. O'Brien
JAMA 2007; 298: 333-334. [Extract] [Full text] [PDF]  

Capitol Health Call
Diabetes Drug Warning

Mike Mitka
JAMA 2007; 298: 166. [Extract] [Full text] [PDF]  

From the Centers for Disease Control and Prevention
Postmarketing Monitoring of Intussusception After RotaTeq^TM Vaccination—United States, February 1, 2006–February 15, 2007

JAMA 2007; 297: 1972-1976. [Extract] [Full text] [PDF]  

Letters
Use of Alendronate After 5 Years of Treatment

Pierre D. Delmas
JAMA 2007; 297: 1979-b-1980-b. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59